Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment OptionsInfectious Diseases and TherapyFebruary 7, 2026
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in GreeceInfectious Diseases and TherapyFebruary 7, 2026
